Source comparison
Comparison Table: MK-677 vs. Other Growth Hormone Peptides
It can be helpful to see how MK-677 stacks up against other popular compounds used to study the GH axis. Each has a unique profile of benefits and metabolic impact. Mechanism Ghrelin Receptor Agonist GHRH / GHRP Analogs Direct GH Replacement Administration Ora
This comparison does not assign a generated winner or score.
- It can be helpful to see how MK-677 stacks up against other popular compounds used to study the GH axis. Each has a unique profile of benefits and metabolic impact.
- Mechanism
- Ghrelin Receptor Agonist
- GHRH / GHRP Analogs
- Direct GH Replacement
- Administration
- Oral (Capsule/Liquid)
- Subcutaneous Injection
- Effect on GH
- Strong, sustained elevation
- Sharp, clean pulse mimicking natural release
- Supraphysiological, flat elevation
- Blood Sugar Impact
- Moderate to Significant
- Mild to Moderate
- Significant to Severe
- Effect on Cortisol
- Can slightly increase cortisol initially
- Virtually no effect on cortisol
- No direct effect on cortisol
- Effect on Hunger
- Significant increase
- Minimal to no increase
- Half-Life
- ~24 hours
- ~30 minutes (Ipamorelin), Days (CJC w/ DAC)
- ~3-4 hours
- As you can see, while peptide combinations like CJC-1295/Ipamorelin still increase GH, their pulsatile nature is often considered gentler on insulin sensitivity compared to the round-the-clock elevation caused by MK-677. This is a critical consideration during the design phase of any experiment.